Literature DB >> 28110167

Chiral separation of new sulfonamide derivatives and evaluation of their enantioselective affinity for human carbonic anhydrase II by microscale thermophoresis and surface plasmon resonance.

Tiphaine Rogez-Florent1, Catherine Foulon2, Anne-Sophie Drucbert3, Nadège Schifano4, Perrine Six5, Stéphanie Devassine6, Patrick Depreux7, Pierre-Marie Danzé8, Laurence Goossens9, Cécile Danel10, Jean-François Goossens11.   

Abstract

The aim of this study was to develop a method combining chiral separation and biophysical techniques to evaluate the enantioselective affinity of original sulfonamide derivatives towards their therapeutic target, the human carbonic anhydrase II (hACII). The first step consisted in the preparation of the enantiomers by chromatographic separation. The performances of HPLC and Supercritical Fluid Chromatography (SFC) were studied at the analytical scale by optimization of various experimental conditions using adsorbed polysaccharide chiral stationary phases (amylose AD-H and cellulose OD-H). Since SFC allowed obtaining higher enantioresolutions per time unit, it was selected for the semi-preparative scale and successfully used to isolate each enantiomer with a satisfactory enantiomeric purity (>98%). Secondly, microscale thermophoresis (MST) method and surface plasmon resonance (SPR) used as reference method were developed to measure potential enantioselective affinities of these enantiomers towards the hACII. The optimizations of both methods were performed using a reference compound, i.e. acetazolamide, which affinity for hCAII has previously been demonstrated. For all compounds, KD values obtained using MST and SPR were in good agreement, leading to similar affinity scales despite both approaches totally differ (labeling for MST versus immobilization of the protein for SPR). The equilibrium dissociation constants of our original compounds for the hCAII were in the range 100-1000nM and an enantioselectivity was observed using the MST and SPR methods for the diarylpyrazole 2. Finally, by comparing the MST and SPR techniques, MST appears especially adapted for further screening of a series of sulfonamide derivatives due to the lower time required to estimate a binding constant while consuming as little hCAII as SPR.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chiral supercritical fluid chromatography; Diarylpyrazole sulfonamides; Human carbonic anhydrase II; Microscale thermophoresis; Surface plasmon resonance

Mesh:

Substances:

Year:  2017        PMID: 28110167     DOI: 10.1016/j.jpba.2017.01.023

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Potent antibacterial activity of MSI-1 derived from the magainin 2 peptide against drug-resistant bacteria.

Authors:  Lingman Ma; Xin Xie; Hanhan Liu; Ya Huang; Haomin Wu; Meiling Jiang; Pengfei Xu; Xinyue Ye; Changlin Zhou
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

2.  Enzymatic characterization and molecular mechanism of a novel aspartokinase mutant M372I/T379W from Corynebacterium pekinense.

Authors:  Yunna Gao; Caijing Han; Chunlei Liu; Ji Wang; Lan Zhao; Li Fang; Weihong Min
Journal:  RSC Adv       Date:  2019-07-09       Impact factor: 4.036

Review 3.  Chiral Capillary Electrokinetic Chromatography: Principle and Applications, Detection and Identification, Design of Experiment, and Exploration of Chiral Recognition Using Molecular Modeling.

Authors:  Sami El Deeb; Camilla Fonseca Silva; Clebio Soares Nascimento Junior; Rasha Sayed Hanafi; Keyller Bastos Borges
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

4.  Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors.

Authors:  İlhami Gulçin; Malahat Abbasova; Parham Taslimi; Zübeyir Huyut; Leyla Safarova; Afsun Sujayev; Vagif Farzaliyev; Şükrü Beydemir; Saleh H Alwasel; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.